HIVE Blockchain Technologies (CVE:HIV – Get Free Report) was downgraded by investment analysts at Keefe, Bruyette & Woods from a “moderate buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday,Zacks.com reports.
Separately, B. Riley raised HIVE Blockchain Technologies to a “strong-buy” rating in a report on Friday, November 21st. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Buy”.
View Our Latest Stock Analysis on HIV
HIVE Blockchain Technologies Price Performance
Featured Stories
- Five stocks we like better than HIVE Blockchain Technologies
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
